Cushing’s Syndrome
Cushing’s syndrome is a disorder of chronic glucocorticoid excess, resulting in widespread metabolic, cardiovascular, immune, and musculoskeletal dysfunction. It may arise from endogenous overproduction of cortisol or from prolonged exposure to exogenous glucocorticoids. Unlike acute stress responses, cortisol excess in Cushing’s syndrome is sustained and unregulated. Symptoms develop gradually, multiple organ systems are affected simultaneously, and individuals are highly vulnerable to infection, cardiovascular disease, and metabolic complications.
What You Need to Know
Cushing’s syndrome develops when cortisol levels remain persistently elevated, overwhelming the body’s normal regulatory systems. Cortisol normally supports glucose availability, vascular tone, and the stress response, but chronic excess shifts its effects from adaptive to harmful. Instead of maintaining stability, sustained cortisol exposure promotes tissue breakdown, impairs repair processes, and disrupts hormonal feedback control across multiple systems.
Excess cortisol alters metabolism in a predictable but damaging way. Glucose production increases while peripheral glucose uptake is impaired, promoting hyperglycaemia and insulin resistance. Protein breakdown accelerates, leading to muscle wasting and thinning of connective tissue, while fat distribution becomes abnormal due to altered lipid metabolism and adipocyte function. At the same time, immune activity is suppressed and inflammatory responses are blunted, increasing susceptibility to infection and impairing wound healing.
Several core physiological effects drive the clinical picture seen in Cushing’s syndrome:
Increased gluconeogenesis and insulin resistance leading to hyperglycaemia
Protein catabolism causing muscle weakness and skin fragility
Altered fat metabolism producing central fat accumulation
Enhanced vascular sensitivity to catecholamines contributing to hypertension
These effects occur regardless of whether cortisol excess arises from endogenous overproduction or exogenous steroid exposure. Over time, prolonged cortisol elevation destabilises metabolic, cardiovascular, immune, and musculoskeletal systems simultaneously, producing the characteristic multisystem manifestations of Cushing’s syndrome rather than isolated endocrine dysfunction.
Beyond the Basics
Chronic cortisol excess and metabolic reprogramming
Cortisol has a central role in regulating energy availability, particularly during stress. It promotes hepatic gluconeogenesis, limits peripheral glucose uptake, and antagonises insulin action. In Cushing’s syndrome, sustained cortisol excess produces persistent hyperglycaemia and insulin resistance. Over time, pancreatic beta cells increase insulin secretion in an attempt to compensate, but this response is often insufficient, increasing the risk of secondary diabetes mellitus.
Cortisol also drives protein catabolism. Muscle and connective tissue are broken down, releasing amino acids that are diverted toward glucose production rather than tissue maintenance. This process leads to proximal muscle weakness, thinning of the skin, easy bruising, and impaired wound healing. Structural integrity is lost gradually, explaining why functional decline may precede overt physical signs.
Redistribution of adipose tissue
Cortisol alters fat metabolism in a region-specific manner rather than simply increasing total fat mass. Lipolysis is enhanced in peripheral adipose tissue, while fat deposition increases centrally, particularly in the face, neck, supraclavicular region, and trunk. These regional differences relate to variations in cortisol sensitivity and local enzyme activity within adipocytes.
Central adiposity contributes to insulin resistance, dyslipidaemia, and increased cardiovascular risk. At the same time, loss of peripheral fat and muscle bulk accentuates limb thinning, producing the characteristic body habitus associated with chronic hypercortisolism.
Vascular effects and hypertension
Cortisol increases vascular sensitivity to catecholamines, making blood vessels more responsive to normal sympathetic stimulation. It also promotes sodium retention at the renal level, even when aldosterone concentrations are not elevated. Together, these effects lead to sustained vasoconstriction, expanded intravascular volume, and persistent hypertension. Chronic elevation in blood pressure increases the risk of cardiovascular disease, stroke, and renal impairment. In this context, hypertension arises from hormonal amplification of vascular tone and volume status rather than intrinsic cardiac dysfunction.
Immune suppression and impaired inflammation
Cortisol suppresses multiple aspects of immune function. Prolonged exposure reduces cytokine production, impairs leukocyte migration, and dampens immune surveillance. Inflammatory responses become muted, which can mask typical signs of infection such as fever, redness, or swelling. This suppression increases susceptibility to infection and contributes to delayed recognition of illness and poor wound healing. Because these effects develop gradually, immune compromise may not be apparent until complications occur.
Loss of normal endocrine feedback
In endogenous forms of Cushing’s syndrome, persistently elevated cortisol disrupts normal regulation of the hypothalamic–pituitary–adrenal axis. Feedback inhibition becomes ineffective, allowing cortisol secretion to remain inappropriately high despite already excessive levels.
In exogenous corticosteroid exposure, endogenous cortisol production is suppressed due to prolonged negative feedback. Abrupt withdrawal of steroids in this setting can precipitate adrenal insufficiency, as adrenal function remains suppressed rather than immediately recovering. This distinction explains why careful tapering is required and why symptoms of cortisol deficiency may emerge after treatment of cortisol excess.
Clinical Connections
Clinical features of Cushing’s syndrome usually develop gradually and may be overlooked early. Progressive weight gain with central fat accumulation, proximal muscle weakness, hypertension, glucose intolerance, skin fragility, and increased susceptibility to infection arise from sustained cortisol excess affecting multiple physiological systems at the same time. Muscle weakness limits mobility and functional capacity, while skin thinning and impaired repair increase bruising and wound complications.
Neuropsychological changes are common and may include mood disturbance, anxiety, depression, irritability, sleep disruption, and impaired concentration or memory. These features arise from prolonged cortisol exposure within the central nervous system, where excess glucocorticoids alter neuronal signalling and stress regulation. Cognitive and psychological symptoms may significantly affect quality of life and adherence to treatment, even when physical signs appear mild.
Periods of physiological stress place individuals at particular risk of deterioration:
Surgery, infection, or acute illness increasing cortisol demand
Abrupt cessation or rapid reduction of exogenous corticosteroids
Intercurrent illness in the presence of suppressed endogenous adrenal function
In these settings, compensatory mechanisms may fail, leading to hypotension, hypoglycaemia, or features of adrenal insufficiency. Appreciating the underlying hormonal physiology explains why long-term corticosteroid exposure requires careful tapering and why individuals with Cushing’s syndrome may deteriorate quickly when stress exceeds their reduced adaptive capacity.
Concept Check
How does chronic cortisol excess alter glucose and protein metabolism?
Why does Cushing’s syndrome cause central fat accumulation with peripheral muscle wasting?
How does cortisol excess contribute to persistent hypertension?
Why are infections harder to detect in individuals with Cushing’s syndrome?
Why can abrupt withdrawal of corticosteroids precipitate adrenal insufficiency?